ARCT - Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q1 2022 Results - Earnings Call Transcript

Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2022 Results Earnings Conference Call May 9, 2022, 04:30 PM ET Company Participants Deepankar Roy - Senior Director, Investor Relations Joseph Payne - President and Chief Executive Officer Andrew Sassine - Chief Financial Officer Pad Chivukula - Chief Scientific Officer and Chief Operating Officer Conference Call Participants Yasmeen Rahimi - Piper Sandler Evan Wang - Guggenheim Partners Nick Abbott - Wells Fargo Securities Yigal Nochomovitz – Citigroup Kumaraguru Raja - Brookline Capital Markets Steven Seedhouse - Raymond James & Associates Thomas Yip - H.C. Wainwright & Co. Presentation Operator Good day. And welcome to the Arcturus Therapeutics First Quarter 2022 Earnings Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Deepankar Roy, Senior Director of Investor Relations. Please go ahead, sir. Deepankar Roy Thank you, James. Good afternoon and welcome to Arcturus Therapeutics First Quarter

For further details see:

Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q1 2022 Results - Earnings Call Transcript